Product Information
OXCARBAZEPINE 300 MG TABLET is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $0.1664 per EA under NDC 51991005405. Its NADAC has been published 46 times since Aug 13, 2025.
Strength
300 mg/1
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991005405
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXCARBAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA078069On Market Since
1/11/2008
Pharmacological Classes
Price Statistics
The NADAC for OXCARBAZEPINE 300 MG TABLET has been published 46 times since Aug 13, 2025, and over the history we have for it it has declined 4.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1664 per EA |
|---|---|
| All-time high | $0.1749 (Aug 13, 2025) |
| All-time low | $0.1664 (Jun 17, 2026) |
| 52-week high | $0.1749 |
| 52-week low | $0.1664 |
| Median price | $0.1721 |
| Average price | $0.1709 |
| Largest weekly change | -1.9% (Feb 18, 2026) |
| Weeks tracked | 46 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXCARBAZEPINE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG TABLET, manufactured by Breckenridge Pharmaceutical Inc., is $0.1664 per EA (NDC 51991005405), effective Jun 24, 2026.
How has the price of OXCARBAZEPINE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG TABLET has declined 4.9%. It has been tracked across 46 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG TABLET?
Since Aug 13, 2025, the NADAC for OXCARBAZEPINE 300 MG TABLET has ranged from a low of $0.1664 (Jun 17, 2026) to a high of $0.1749 (Aug 13, 2025), with a median of $0.1721 per EA.
Are there cheaper alternatives to OXCARBAZEPINE 300 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as OXCARBAZEPINE 300 MG TABLET, but none are currently priced below it.
Who manufactures OXCARBAZEPINE 300 MG TABLET?
OXCARBAZEPINE 300 MG TABLET (NDC 51991005405) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification